RC
BLFS icon

Roubaix Capital’s BioLife Solutions BLFS Stock Holding History

Roubaix Capital’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-123,199
Closed -$2.29M – 51
2024
Q1 		$2.29M Sell
123,199
-157,138
-56% -$2.75M 1.45% 31
2023
Q4 		$4.56M Buy
280,337
+133,439
+91% +$1.7M 3.19% 9
2023
Q3 		$2.03M Buy
+146,898
New +$2.31M 1.5% 36
2020
Q2 		– Sell
-221,008
Closed -$2.1M – 52
2020
Q1 		$2.1M Buy
221,008
+82,700
+60% +$1.14M 3.19% 10
2019
Q4 		$2.24M Buy
138,308
+58,584
+73% +$952K 2.15% 25
2019
Q3 		$1.32M Sell
79,724
-40,589
-34% -$762K 1.21% 31
2019
Q2 		$2.04M Buy
120,313
+75,068
+166% +$1.31M 1.7% 27
2019
Q1 		$809K Buy
+45,245
New +$720K 0.8% 38

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Roubaix Capital's BLFS Position: Q2 2024 in Review

Roubaix Capital sold out of BioLife Solutions (BLFS) in Q2 2024, closing a stake of 123,199 shares — an estimated $2.29M sold.

Roubaix Capital first reported a position in BLFS in Q1 2019 and held it in 8 quarters. The position peaked at $4.56M in Q4 2023. 164 funds tracked by Wall St. Rank hold BLFS as of Q2 2024.

  • Roubaix Capital reported no remaining BioLife Solutions position as of Q2 2024 after selling out during the quarter.
  • Roubaix Capital sold 123,199 BioLife Solutions shares in Q2 2024, an estimated $2.29M.
  • Roubaix Capital first reported a position in BioLife Solutions in Q1 2019 and held it in 8 quarters.
  • Roubaix Capital's BioLife Solutions position peaked at $4.56M in Q4 2023.
  • 164 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2024.

Based on Roubaix Capital's 13F filing for Q2 2024, filed 2 Aug 2024.